597 related articles for article (PubMed ID: 32540643)
1. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.
Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ
Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.
Sun Q; Guo S; Wang CC; Sun X; Wang D; Xu N; Jin SF; Li KZ
Int J Clin Exp Pathol; 2015; 8(6):7631-9. PubMed ID: 26261683
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Inflammation in Keloid and Hypertrophic Scars.
Wang ZC; Zhao WY; Cao Y; Liu YQ; Sun Q; Shi P; Cai JQ; Shen XZ; Tan WQ
Front Immunol; 2020; 11():603187. PubMed ID: 33343575
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
5. Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.
Wang X; Qian Y; Jin R; Wo Y; Chen J; Wang C; Wang D
PLoS One; 2013; 8(2):e55899. PubMed ID: 23418473
[TBL] [Abstract][Full Text] [Related]
6. Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway.
Wang XM; Liu XM; Wang Y; Chen ZY
Bioengineered; 2021 Dec; 12(1):117-126. PubMed ID: 33315500
[TBL] [Abstract][Full Text] [Related]
7. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway.
Ji X; Tang Z; Shuai W; Zhang Z; Li J; Chen L; Cao J; Yin W
Life Sci; 2019 Aug; 231():116674. PubMed ID: 31344427
[TBL] [Abstract][Full Text] [Related]
8. Exosomes from miR-29a-modified adipose-derived mesenchymal stem cells reduce excessive scar formation by inhibiting TGF-β2/Smad3 signaling.
Yuan R; Dai X; Li Y; Li C; Liu L
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476508
[TBL] [Abstract][Full Text] [Related]
9. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of keloid and hypertrophic scar formation.
Tuan TL; Nichter LS
Mol Med Today; 1998 Jan; 4(1):19-24. PubMed ID: 9494966
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
12. Smad interacting protein 1 influences transforming growth factor-β
Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
[TBL] [Abstract][Full Text] [Related]
13. The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.
Chen J; Zeng B; Yao H; Xu J
Burns; 2013 May; 39(3):465-72. PubMed ID: 22981800
[TBL] [Abstract][Full Text] [Related]
14. Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts.
Younai S; Nichter LS; Wellisz T; Reinisch J; Nimni ME; Tuan TL
Ann Plast Surg; 1994 Aug; 33(2):148-51. PubMed ID: 7979045
[TBL] [Abstract][Full Text] [Related]
15. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
17. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
18. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
20. [Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar].
Tang S; Pang S; Cao Y
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Jul; 15(4):283-5. PubMed ID: 11593607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
